ijms-logo

Journal Browser

Journal Browser

Neuroproteomics: Focus on Nervous System Function and Disease

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 20 January 2025 | Viewed by 347

Special Issue Editor


E-Mail
Guest Editor
ELTE NAP Neuroimmunology Research Group, Department of Biochemistry, Institute of Biology, ELTE Eötvös Loránd University, H-1117 Budapest, Hungary
Interests: proteomics; synapse; dopaminergic system; neurotransmitter transporters; neuroimmune crosstalk; neurodegenerative disorders; protein–protein interactions

Special Issue Information

Dear Colleagues,

Given its outstanding heterogeneity and complexity, deciphering the cellular- and network-level mechanisms of the nervous system has been challenging, which is reflected by severe hurdles in developing efficacious pharmacological compounds without manifesting prohibiting off-target effects. Due to the major impact of neuroproteomics in shaping our understanding of the biology of the nervous system, in this Special Issue, we encourage researchers to present their latest studies focusing on the nervous system utilizing proteomics tools either conducted in vivo or in cell culture experiments. Despite constant methodological developments, significant limitations still exist in neuroproteomics that might hinder unmasking protein-level data in sufficient detail. Consequently, technical developments/refinements in sample preparation, protein identification/quantification, and bioinformatics to improve neuroproteomics data collection are within the scope of this Special Issue. Beyond original research articles, reviews and opinions, providing summaries, newly formulated hypotheses and raising current challenges within neuroproteomics are also welcome.

Dr. Balázs András Györffy
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • proteomics
  • neuronal communication
  • pathomechanism of nervous system disorders
  • synapse
  • mass spectrometry

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

21 pages, 9903 KiB  
Review
Proteomics Studies on Extracellular Vesicles Derived from Glioblastoma: Where Do We Stand?
by Patricia Giuliani, Chiara De Simone, Giorgia Febo, Alessia Bellasame, Nicola Tupone, Vimal Di Virglio, Fabrizio di Giuseppe, Renata Ciccarelli, Patrizia Di Iorio and Stefania Angelucci
Int. J. Mol. Sci. 2024, 25(18), 9778; https://doi.org/10.3390/ijms25189778 - 10 Sep 2024
Abstract
Like most tumors, glioblastoma multiforme (GBM), the deadliest brain tumor in human adulthood, releases extracellular vesicles (EVs). Their content, reflecting that of the tumor of origin, can be donated to nearby and distant cells which, by acquiring it, become more aggressive. Therefore, the [...] Read more.
Like most tumors, glioblastoma multiforme (GBM), the deadliest brain tumor in human adulthood, releases extracellular vesicles (EVs). Their content, reflecting that of the tumor of origin, can be donated to nearby and distant cells which, by acquiring it, become more aggressive. Therefore, the study of EV-transported molecules has become very important. Particular attention has been paid to EV proteins to uncover new GBM biomarkers and potential druggable targets. Proteomic studies have mainly been performed by “bottom-up” mass spectrometry (MS) analysis of EVs isolated by different procedures from conditioned media of cultured GBM cells and biological fluids from GBM patients. Although a great number of dysregulated proteins have been identified, the translation of these findings into clinics remains elusive, probably due to multiple factors, including the lack of standardized procedures for isolation/characterization of EVs and analysis of their proteome. Thus, it is time to change research strategies by adopting, in addition to harmonized EV selection techniques, different MS methods aimed at identifying selected tumoral protein mutations and/or isoforms due to post-translational modifications, which more deeply influence the tumor behavior. Hopefully, these data integrated with those from other “omics” disciplines will lead to the discovery of druggable pathways for novel GBM therapies. Full article
(This article belongs to the Special Issue Neuroproteomics: Focus on Nervous System Function and Disease)
Show Figures

Figure 1

Back to TopTop